Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2321-2026Class II

Bicarby" Dialysate; Model Numbers: RFP-400-G, RFP-401-G, RFP-402-G, RFP-404-G, RFP-407-G, and RFP-456-G

Fresenius Medical Care Renal Therapies Group, LLC / initiated 2026-05-12 / Open, Classified / root cause: manufacturing process

Fresenius Medical Care Holdings, Inc. began a recall of Bicarby" Dialysate; Model Numbers: RFP-400-G, RFP-401-G, RFP-402-G, RFP-404-G, RFP-407-G, and RFP-456-G on . FDA classified it as Class II and gives the reason as "Given the increased number of leaks reported by users, it was determined to be the appropriate course of action to notify users of the potential for the occurrence of Bicarby luer-lock leaks during manipulation of the...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2321-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Fresenius Medical Care Renal Therapies Group, LLC
Product
Bicarby" Dialysate; Model Numbers: RFP-400-G, RFP-401-G, RFP-402-G, RFP-404-G, RFP-407-G, and RFP-456-G;
Product code
KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Reason for recall
Given the increased number of leaks reported by users, it was determined to be the appropriate course of action to notify users of the potential for the occurrence of Bicarby luer-lock leaks during manipulation of the frangible and tubing when preparing the product for use for treatment. This issue presents the potential of a slip and fall hazard associated with fluid on the floor.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
On 5/12/2026 an IMPORTANT MEDICAL DEVICE INFORMATION letters were sent to customers to inform them that manipulation of the luer-lock location during treatment preparation may result in fluid spillage onto the user and floor. This occurs prior to treatment and renders the product unusable. Direct contact with the fluid does not present any risk to the user as frangible manipulation only occurs after the peal seam has been broken and the two fluid compartments have been mixed. The potential risk associated with the affected Bicarby Dialysate product is a slip and fall hazard due to the presence of fluid on the floor.
Quantity in commerce
1,756,108 units
Distribution
US Nationwide distribution in the states of NY, TN and TX.
Product codes and lots
Model Number: RFP-400-G; UDI-DI: 00840861102839; 2. Model Number: RFP-401-G; UDI-DI: 00840861102853; 3. Model Number: RFP-402-G; UDI-DI: 00840861102822; 4. Model Number: RFP-404-G; UDI-DI: 00840861102914; 5. Model Number: RFP-407-G; UDI-DI: 00840861102846: 6. Model Number: RFP-456-G; UDI-DI: 00840861102945; All lots produced from January 13, 2025, through lot 26AG02019 on January 13, 2026

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2321-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2321-2026Class IIOngoingVoluntary: Firm initiated